CMV research is an emerging field, but there are a variety of research studies, clinical trials, and state-level legislation underway. We provide the necessary CMV findings, resources, and information to best equip your tribe for managing a congenital CMV diagnosis.
Learn more about how CMV is garnering media attention around the world and web.
Empowered CMV families from across the nation have teamed up with professionals and politicians in several states in hopes of making a difference with CMV legislation!
In these last 55 years, definite strides have been made in the field of CMV research, including the development and administration of antiviral treatments and vaccine candidates.
Recent studies indicate that CMV-IGIV treatment may reduce the risk of congenital infection and/or neonatal disease when given to pregnant women experiencing a primary CMV infection.
There is no CMV vaccine available to prevent congenital CMV. Many experts believe that a CMV vaccine is possible within the next 10 to 20 years, but a CMV vaccine is unlikely to occur without a significant increase in awareness.
For congenital CMV, two main registries exist that are focused around pregnant women who acquire CMV during pregnancy and children who are born symptomatic with congenital CMV.